Drug Information

General Information
Drug ID
DR00061
Drug Name
Aliskiren fumarate
Synonyms
(2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methyl-2-(propan-2-yl)nonanamide; (2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide; (2S,4S,5S,7S)-N-(2-Carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-[4-methoxy-3-(3-methoxypropoxy)phenyl]octanamide; Aliskiren (USAN/INN); Octanamide, .delta.-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-.gamma.-hydroxy-4-methoxy-3-(3-methoxypropoxy)-.alpha.,.zeta.-bis(1-methylethyl)-, [.alpha.S-(alpha.R*,.gamma.R*,.delta.R*,.zeta.R*)]; Rasilez; Rasilez (TN); SPP 100; Tekturna (TN)
Drug Type
Small molecular drug
Indication High blood pressure [ICD11: BA00] Approved [1]
Therapeutic Class
Antihypertensive Agents
Structure
3D MOL 2D MOL
Formula
C30H53N3O6
Canonical SMILES
CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
InChI
InChI=1S/C30H53N3O6/c1-19(2)22(14-21-10-11-26(38-8)27(15-21)39-13-9-12-37-7)16-24(31)25(34)17-23(20(3)4)28(35)33-18-30(5,6)29(32)36/h10-11,15,19-20,22-25,34H,9,12-14,16-18,31H2,1-8H3,(H2,32,36)(H,33,35)/t22-,23-,24-,25-/m0/s1
InChIKey
UXOWGYHJODZGMF-QORCZRPOSA-N
CAS Number
CAS 173334-57-1
Pharmaceutical Properties Molecular Weight 551.8 Topological Polar Surface Area 146
Heavy Atom Count 39 Rotatable Bond Count 19
Hydrogen Bond Donor Count 4 Hydrogen Bond Acceptor Count 7
XLogP
3.5
PubChem CID
5493444
PubChem SID
103615727 , 104178818 , 114001043 , 124897540 , 126666078 , 129435102 , 134338459 , 135916045 , 137002989 , 137227121 , 140385193 , 14763777 , 14886049 , 151991991 , 152028160 , 152258402 , 160647239 , 160964589 , 162181387 , 17397362 , 174006809 , 175268617 , 176485078 , 177748803 , 178101514 , 179150066 , 185997039 , 187032771 , 223393380 , 223404348 , 223435288 , 223661693 , 223720068 , 224032552 , 226775246 , 242591596 , 251916704 , 251917943 , 251970968 , 252213891 , 39475202 , 46507474 , 46509572 , 51009124 , 7980347 , 85176969 , 87324641 , 96099933
ChEBI ID
CHEBI:601027
TTD Drug ID
D03SVX
DT(s) Transporting This Drug OATP2B1 Transporter Info Organic anion transporting polypeptide 2B1 Substrate [2]
P-GP Transporter Info P-glycoprotein 1 Substrate [3]
References
1 Wockhardt Ltd.: Aliskiren fumarate
2 Orange and apple juice greatly reduce the plasma concentrations of the OATP2B1 substrate aliskiren. Br J Clin Pharmacol. 2011 May;71(5):718-26.
3 Effects of the inhibition of intestinal P-glycoprotein on aliskiren pharmacokinetics in cynomolgus monkeys. Biopharm Drug Dispos. 2015 Jan;36(1):15-33.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.